Neuroendocrine control of food intake
- PMID: 18061414
- DOI: 10.1016/j.numecd.2007.06.004
Neuroendocrine control of food intake
Abstract
Appetite is regulated by a complex system of central and peripheral signals which interact in order to modulate the individual response to nutrient ingestion. Peripheral regulation includes satiety signals and adiposity signals, while central control is accomplished by several effectors, including the neuropeptidergic, monoaminergic and endocannabinoid systems. Satiety signals, including cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), originate from the gastrointestinal (GI) tract during a meal and, through the vagus nerve, reach the nucleus tractus solitarius (NTS) in the caudal brainstem. From NTS afferents fibers project to the arcuate nucleus (ARC), where satiety signals are integrated with adiposity signals, namely leptin and insulin, and with several hypothalamic and supra-hypothalamic inputs, thus creating a complex network of neural circuits which finally elaborate the individual response to a meal. As for the neuropeptidergic system, ARC neurons secrete orexigenic substances, such as neuropeptide Y (NPY) and agouti-related peptide (AGRP), and anorexigenic peptides such as pro-opiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART). Other brain areas involved in the control of food intake are located downstream the ARC: among these, the paraventricular nucleus (PVN), which produces anorexigenic peptides such as thyrotropin releasing hormone (TRH), corticotrophin releasing hormone (CRH) and oxytocin, the lateral hypothalamus (LHA) and perifornical area (PFA), secreting the orexigenic substances orexin-A (OXA) and melanin concentrating hormone (MCH). A great interest in endocannabinoids, important players in the regulation of food intake, has recently developed. In conclusion, the present work reviews the most recent insights into the complex and redundant molecular mechanisms regulating food intake, focusing on the most encouraging perspectives for the treatment of obesity.
Similar articles
-
Neuro-hormonal control of food intake: basic mechanisms and clinical implications.J Physiol Pharmacol. 2005 Dec;56 Suppl 6:5-25. J Physiol Pharmacol. 2005. PMID: 16340035 Review.
-
Brain-gut axis and its role in the control of food intake.J Physiol Pharmacol. 2004 Mar;55(1 Pt 2):137-54. J Physiol Pharmacol. 2004. PMID: 15082874 Review.
-
Role of neuropeptides in appetite regulation and obesity--a review.Neuropeptides. 2006 Dec;40(6):375-401. doi: 10.1016/j.npep.2006.07.001. Epub 2006 Aug 28. Neuropeptides. 2006. PMID: 16935329 Review.
-
Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.Neuroscience. 2005;132(1):167-73. doi: 10.1016/j.neuroscience.2004.11.037. Neuroscience. 2005. PMID: 15780475
-
[The regulation of body mass and its relation to the development of obesity].Orv Hetil. 2007 Sep 30;148(39):1827-36. doi: 10.1556/OH.2007.28085. Orv Hetil. 2007. PMID: 17890170 Review. Hungarian.
Cited by
-
The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress.Biomedicines. 2024 Feb 17;12(2):448. doi: 10.3390/biomedicines12020448. Biomedicines. 2024. PMID: 38398050 Free PMC article. Review.
-
Expression of Genes Encoding Selected Orexigenic and Anorexigenic Peptides and Their Receptors in the Organs of the Gastrointestinal Tract of Calves and Adult Domestic Cattle (Bos taurus taurus).Int J Mol Sci. 2023 Dec 31;25(1):533. doi: 10.3390/ijms25010533. Int J Mol Sci. 2023. PMID: 38203717 Free PMC article.
-
Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition.Diabetes Metab J. 2023 Nov;47(6):784-795. doi: 10.4093/dmj.2022.0261. Epub 2023 Aug 23. Diabetes Metab J. 2023. PMID: 37915185 Free PMC article.
-
The Effects of Ketogenic Diet on Insulin Sensitivity and Weight Loss, Which Came First: The Chicken or the Egg?Nutrients. 2023 Jul 12;15(14):3120. doi: 10.3390/nu15143120. Nutrients. 2023. PMID: 37513538 Free PMC article. Review.
-
In silico clinical trial evaluating lisdexamfetamine's and methylphenidate's mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients' population.Front Psychiatry. 2023 Jun 2;14:939650. doi: 10.3389/fpsyt.2023.939650. eCollection 2023. Front Psychiatry. 2023. PMID: 37333910 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
